Urogen Pharma Ltd.

Urogen Pharma Ltd. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

• Urogen Pharma Ltd. revenue for the quarter ending March 31, 2026 was 51.0 M, a 151.60% increase year-over-year.
• Urogen Pharma Ltd. revenue for the twelve months ending March 31, 2026 was 122.9 M, a 41.79% increase year-over-year.
• Urogen Pharma Ltd. annual revenue for 2025 was 109.8 M, a 21.45% increase from 2024.
• Urogen Pharma Ltd. annual revenue for 2024 was 90.4 M, a 9.29% increase from 2023.
• Urogen Pharma Ltd. annual revenue for 2023 was 82.7 M, a 28.52% increase from 2022.
• Urogen Pharma Ltd. annual revenue for 2022 was 64.4 M.